Ginebra San Miguel Inc (GSMI)
Philippine Stock Exchange · Philippines · prices in PHP · close of 22 Oct 2026
Key indicators
| Last close | PHP 220.00 |
|---|---|
| 52-week range | 199.00 – 305.00 |
| Return, 1 month / 3 months | +2.6% / −16.1% |
| Return, 1 year / 3 years | −19.0% / +41.5% |
| Trend | Below its 200-day average |
| RSI (14) | 51 |
| Volatility (1 year) | 22.8% |
| Worst drawdown (1 year) | -32.3% |
| Average daily value traded | 15.57M PHP |
| Dividend yield | 3.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ginebra San Miguel Inc is a Philippine beverage company that distils and markets spirits, chiefly gin sold under the Ginebra San Miguel name, along with brandy and other liquor products. Its customers are adult drinkers in the Philippines, reached through retailers, bars and stores across the country. The company is based in the Philippines and forms part of the San Miguel group of businesses, drawing on a long history of local distilling.
The shares are listed on the Philippine Stock Exchange in Philippines under the code GSMI, and the price on this page is in Philippine pesos (PHP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Ginebra San Miguel Inc (GSMI) trades on the Philippine Stock Exchange in Philippines. It last closed at PHP 220.00 on 22 October 2026.
Its price-based Market X-Ray is 40 out of 100 (a weak price profile), ranking 167 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 19.0% and over the last three months it fell 16.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Philippine Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 17 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -15.0% | ||
| From 52-week high | -26.9% | ||
| Momentum | 12 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -16.1% | ||
| 6-month return | -18.1% | ||
| 12-month return, skipping the last month | -21.1% | ||
| Stability (higher is calmer) | 59 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 22.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.3% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 15.57M PHP | ||
| Zero-volume days | 0.0% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.6% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +0.5% |
|---|---|
| 1 month | +2.6% |
| 3 months | −16.1% |
| 6 months | −18.1% |
| 1 year | −19.0% |
| 3 years | +41.5% |
| 5 years | +133.5% |
Signals
| 50-day / 200-day average | 221.12 / 258.88 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.87 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 Aug 2026 | PHP 2.0000 |
| 18 May 2026 | PHP 2.0000 |
| 19 Mar 2026 | PHP 1.5000 |
| 19 Nov 2025 | PHP 2.5000 |
| 19 Aug 2025 | PHP 2.5000 |
| 19 May 2025 | PHP 1.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Philippine Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.